GSI-FAIR Colloquium

# Life, the Universe and Everything

## by Ulli Köster (ILL Grenoble & Univ. Grenoble Alpes)

Tuesday, November 12, 2019 from to (Europe/Berlin)
at GSI ( Main Lecture Hall )
 Description ILL Grenoble is well-known for its research with intense neutron beams, but its high-flux reactor also permits transmuting stable targets into radionuclides, useful e.g. in nuclear medicine. For long time therapeutic applications of radiopharmaceuticals were restricted to few, relatively rare diseases (e.g. thyroid cancer), but new targeted radionuclide therapies for different types of cancer (e.g. prostate cancer) and other diseases are now coming into clinical practice. Here the development of novel targeting molecules goes hand in hand with the transition to appropriate radionuclides with optimum nuclear and chemical properties. Radionuclides with high specific activity and high purity are key ingredients for most nuclear medicine applications, but they also enable interesting experiments in basic research, namely nuclear astrophysics, particle physics and other fields. Examples from recent research with radionuclides in different fields will be presented.